Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-01-14
1992-12-29
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, A61K 3702, C07K 710
Patent
active
051751453
ABSTRACT:
Novel methods for treating diabetes mellitus and hyperglycemia are described which comprise administering to a diabetic or hypoglycemic subject an amount of an amylin agonist effective to induce amylin activity in said subject. Various amylin agonist compounds, and therapeutic methods utilizing such compounds, are also disclosed.
REFERENCES:
patent: 4530839 (1985-07-01), Evans
patent: 4687839 (1987-08-01), Kempe
patent: 4697002 (1987-09-01), Kempe
patent: 4720483 (1988-01-01), Janz
patent: 4736023 (1988-04-01), Evans
Foord et al., Eur. J. Bochem. 170:373 (1987).
Sewell et al., Soc. Neurosci. Abs. 13:42 (1987).
Kimura et al., Neuropeptides 9:75 (1987).
Minvielle et al., FEBS Lett. 203:7 (1986).
Morris et al., Nature 308:746 (1984).
Craig et al., Biochem. Soc. Symp. 52:91 (1986).
Tippins et al., J. Hypertens., 4:5102 (1986).
Tippins et al., Biochem. Biophys. Res. Commun., 134:1306 (1981).
Holman et al., Peptides, 7:231 (1986).
Lenz et al., Gut, 26:550 (1985).
Westermark et al., Biochem. Biophys. Res. Commun. 140:827 (1986).
Westermark et al., Diabetologia, 30:887 (1987).
Westermark, et al., Proc. Nat. Acad. Sci. (USA), 84:3881 (1987).
Westermark et al., Am. J. Pathol., 127:414 (1987).
Cooper et al., Proc. Nat. Acad. Sci. (USA) 84:8628 (1987).
Cooper et al., Lancet 2:966 (1987).
Amylin Pharmaceuticals Inc.
Lee Lester L.
LandOfFree
Treatment of diabetes mellitus with amylin agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diabetes mellitus with amylin agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diabetes mellitus with amylin agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1887108